The FTSE 100 company anticipates its total income, excluding recoveries, expanding by 6.5 per cent to 7.5 per cent at constant currency rates in 2024.Read More

You might also be interested in reading Sana Biotech extends rally as Morgan Stanley cites platform’s potential.